Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

[68Ga]Ga-GZP PET and [18F]FDG PET for Early Response Prediction in Locally Advanced Rectal Cancer Undergoing Neoadjuvant Short-Course Radiotherapy Plus Immunochemotherapy: A Single-center Clinical Study

NCT06982053 is registered in ClinicalTrials.gov with Union Hospital, Tongji Medical College, Huazhong University of Science and Technology as lead sponsor.

NCT NCT06982053
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06982053 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
[68Ga]Ga-GZP PET and [18F]FDG PET for Early Response Prediction in Locally Advanced Rectal Cancer Undergoing Neoadjuvant Short-Course Radiotherapy Plus Immunochemotherapy: A Single-center Clinical Study
Lead sponsor
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Phase
Not applicable
Overall status
Completed
Start date
May 6, 2024
Completion date
March 31, 2025
Enrollment
21 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

colorectal cancer control and prevention, colorectal cancer metastatic, colorectal cancer recurrent, colorectal cancer screening